Go Pro

Vickers Vantage Corp. I (VCKAW) 10K Form and Latest SEC Filings 2026

$0.12 0.00 (-3.98%)
As of 09/4/2026

Latest Vickers Vantage Corp. I SEC Filings & Recent Activity

Vickers Vantage Corp. I (NASDAQ:VCKAW) has submitted 533+ documents to the U.S. Securities and Exchange Commission (SEC) since 2020. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Vickers Vantage Corp. I's financial statements. The most recent filing was a Form SCHEDULE 13D/A submitted on August 24, 2026.

Form 4
Scilex Holding Co Reports Ownership Change on Aug. 24, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Vickers Vantage Corp. I Files Current Report on Aug. 12, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Vickers Vantage Corp. I Files Quarterly Report on May. 20, 2026

The 10-Q contains Vickers Vantage Corp. I's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Vickers Vantage Corp. I SEC Filing History

Browse Vickers Vantage Corp. I's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/24/2026 3:12 PM
Datavault AI Inc. (1682149) Issuer
Vickers Vantage Corp. I (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 3:14 PM
Datavault AI Inc. (1682149) Subject
Vickers Vantage Corp. I (1820190) Filed by
Form SCHEDULE 13D/A
08/12/2026 4:18 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2026 4:30 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2026 8:25 PM
Vickers Vantage Corp. I (1820190) Issuer
SCLX Stock Acquisition JV LLC (1994894) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2026 8:26 PM
Vickers Vantage Corp. I (1820190) Subject
SCLX Stock Acquisition JV LLC (1994894) Filed by
Form SCHEDULE 13D/A
07/06/2026 5:15 AM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2026 4:01 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2026 3:19 PM
Vickers Vantage Corp. I (1820190) Reporting
Scilex, Inc. (2084647) Reporting
Semnur Pharmaceuticals, Inc. (1913577) Issuer
Semnur Pharmaceuticals, Inc. (1913577) Issuer
Semnur Pharmaceuticals, Inc. (1913577) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2026 3:52 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2026 11:15 PM
Vickers Vantage Corp. I (1820190) Filer
Form EFFECT
05/25/2026 11:15 PM
Vickers Vantage Corp. I (1820190) Filer
Form EFFECT
05/20/2026 4:22 PM
Vickers Vantage Corp. I (1820190) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2026 3:32 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2026 3:05 PM
Vickers Vantage Corp. I (1820190) Filer
Form DEFA14A
05/05/2026 12:24 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2026 3:58 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2026 7:52 AM
Ji Henry (1470981) Reporting
Vickers Vantage Corp. I (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2026 7:56 AM
Ma Stephen Hoi (1954364) Reporting
Vickers Vantage Corp. I (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 4:11 PM
Vickers Vantage Corp. I (1820190) Filer
Form S-3
Registration statement under Securities Act of 1933  
04/10/2026 4:29 PM
Vickers Vantage Corp. I (1820190) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2026 5:03 AM
Vickers Vantage Corp. I (1820190) Filer
Form NT 10-K
03/13/2026 11:59 AM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2026 5:03 AM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2026 7:07 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
02/20/2026 7:09 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
02/20/2026 7:11 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
02/20/2026 3:14 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2026 3:10 PM
ORAMED PHARMACEUTICALS INC. (1176309) Filed by
Vickers Vantage Corp. I (1820190) Subject
Form SCHEDULE 13G/A
02/03/2026 4:03 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2026 3:07 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2026 7:16 PM
Datavault AI Inc. (1682149) Subject
Vickers Vantage Corp. I (1820190) Filed by
Form SCHEDULE 13D/A
01/14/2026 7:04 PM
Datavault AI Inc. (1682149) Issuer
Vickers Vantage Corp. I (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 6:49 PM
Datavault AI Inc. (1682149) Subject
Vickers Vantage Corp. I (1820190) Filed by
Form SCHEDULE 13D/A
01/08/2026 5:44 PM
Datavault AI Inc. (1682149) Issuer
Vickers Vantage Corp. I (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 5:02 AM
Vickers Vantage Corp. I (1820190) Filer
Form RW
12/31/2025 7:50 AM
Datavault AI Inc. (1682149) Issuer
Vickers Vantage Corp. I (1820190) Reporting
Form 4/A
12/31/2025 7:54 AM
Datavault AI Inc. (1682149) Subject
Vickers Vantage Corp. I (1820190) Filed by
Form SCHEDULE 13D/A
12/30/2025 7:24 PM
Vickers Vantage Corp. I (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2025 2:37 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2025 11:15 PM
Vickers Vantage Corp. I (1820190) Filer
Form EFFECT
Bank of America: 'Digital Dollar Inevitable' (Ad)

Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.tc pixel

Watch how to access the legal backdoor before it closes.
12/29/2025 3:31 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/22/2025 2:55 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2025 9:42 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/17/2025 9:43 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/17/2025 9:44 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/17/2025 9:28 AM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2025 8:39 PM
Vickers Vantage Corp. I (1820190) Filer
Form S-1
Registration statement under Securities Act of 1933  
12/12/2025 3:40 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/12/2025 3:43 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/12/2025 3:45 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/12/2025 3:16 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 4:27 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 4:27 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/11/2025 4:30 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/11/2025 4:30 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/05/2025 3:38 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/05/2025 3:42 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/05/2025 3:45 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/01/2025 5:30 AM
Datavault AI Inc. (1682149) Subject
Vickers Vantage Corp. I (1820190) Filed by
Form SCHEDULE 13D
12/01/2025 5:15 AM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2025 5:20 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/01/2025 5:21 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
12/01/2025 5:23 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/28/2025 8:41 PM
Datavault AI Inc. (1682149) Issuer
Vickers Vantage Corp. I (1820190) Reporting
Form 3
Initial statement of beneficial ownership of securities  
11/28/2025 8:44 PM
Datavault AI Inc. (1682149) Issuer
Vickers Vantage Corp. I (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 4:26 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/24/2025 4:15 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2025 4:23 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/24/2025 4:25 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/14/2025 4:19 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/14/2025 4:21 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/14/2025 4:24 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/04/2025 1:21 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/04/2025 1:22 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/04/2025 1:23 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
11/04/2025 12:21 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2025 8:12 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
10/31/2025 8:13 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
10/31/2025 8:16 AM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
10/31/2025 7:56 AM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 4:22 PM
Vickers Vantage Corp. I (1820190) Filer
Form PRE 14A
10/14/2025 3:01 PM
Vickers Vantage Corp. I (1820190) Filed by
Semnur Pharmaceuticals, Inc. (1913577) Subject
Semnur Pharmaceuticals, Inc. (1913577) Subject
Semnur Pharmaceuticals, Inc. (1913577) Subject
Form SCHEDULE 13D/A
10/14/2025 3:01 PM
Vickers Vantage Corp. I (1820190) Filer
Form D
Notice of Exempt Offering of Securities 
10/09/2025 7:47 AM
Vickers Vantage Corp. I (1820190) Issuer
Wu Yue Alexander (1682419) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:40 AM
Followwill Dorman (1717947) Reporting
Vickers Vantage Corp. I (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:42 AM
Ji Henry (1470981) Reporting
Vickers Vantage Corp. I (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:43 AM
Chun Jay (1994406) Reporting
Vickers Vantage Corp. I (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:45 AM
Ma Stephen Hoi (1954364) Reporting
Vickers Vantage Corp. I (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2025 3:28 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
10/07/2025 3:24 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
Moderna’s 177% Surge Puts Cancer Biotech Back in Focus (Ad)

Moderna shares surged 177% in a single trading session on August 19, adding about $45 billion in market value after Moderna and Merck reported positive Phase 3 results for an experimental melanoma treatment. GT Biopharma is taking a different approach, using an immunotherapy platform that harnesses Natural Killer cells against cancer without requiring a custom therapy for every patient. Its first-generation TriKE produced bone marrow blast level reductions of up to 63.7%, and preclinical data show a redesigned second-generation version up to 10-40x more potent, with two candidates now in Phase 1 trials.tc pixel

See why this microcap biotech could be nearing a defining moment
10/07/2025 3:26 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
10/07/2025 3:05 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2025 4:14 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 8:39 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
09/26/2025 8:41 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
09/26/2025 8:43 PM
Vickers Vantage Corp. I (1820190) Filer
Form 424B3
09/26/2025 3:10 PM
Vickers Vantage Corp. I (1820190) Filed by
Semnur, Inc. (1584541) Subject
Form SCHEDULE 13D
09/26/2025 3:10 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 3:02 PM
Vickers Vantage Corp. I (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Vickers Vantage Corp. I SEC Filings - Frequently Asked Questions

Vickers Vantage Corp. I (VCKAW) has submitted 533+ filings to the SEC since 2020. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form SCHEDULE 13D/A submitted on August 24, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:VCKAW are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/24/2026. New filings are added as they're published.
From Our Partners